BLTE
Belite Bio Inc ADR
NASDAQ: BLTE · HEALTHCARE · BIOTECHNOLOGY
$154.50
-2.66% today
Updated 2026-04-29
Market cap
$6.17B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.32
Dividend yield
—
52W range
$56 – $200
Volume
0.2M
Belite Bio Inc ADR (BLTE) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | $25.74M | $18.35M | $44.27M | $94.64M | $152.13M |
| Cash & equivalents | — | — | — | — | — |
| Current assets | $25.67M | $17.43M | $42.81M | $89.94M | $147.07M |
| Total liabilities | $32.78M | $33.44M | $2.77M | $4.21M | $6.31M |
| Current liabilities | $972000.00 | $1.64M | $2.10M | $3.63M | $6.05M |
| Long-term debt | — | — | — | — | — |
| Shareholder equity | — | — | — | — | — |
| Retained earnings | $-17.56M | $-27.22M | $-39.87M | $-71.50M | $-107.65M |
| Accounts receivable | $40000.00 | $23000.00 | $19000.00 | $867000.00 | $594000.00 |
| Inventory | — | — | $-19000.00 | — | — |
| Goodwill | — | — | — | — | — |